Peter Attia Drive
Peter Attia Drive

#380 ‒ The seed oil debate: are they uniquely harmful relative to other dietary fats? | Layne Norton, Ph.D.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Layne Norton is a nutrition scientist and accomplished power athlete,who returns to The Drive for a conversation that departs from the show's usual format. In

Featured Speakers

Peter Attia HostLane Norton GuestPeter Attia Guest

Topics Discussed

Episode Summary

Executive Summary: Peter Attia and Lane Norton dissect the seed oil debate through a deliberately rigorous, evidence-based lens, comparing historical RCTs, Mendelian randomization, lipid biology, oxidation mechanisms, and food-processing concerns. They conclude that seed oils are not uniquely harmful in isocaloric substitution, that trans fats and ultra-processed foods are major confounders, and that overall diet quality, caloric excess, LDL/ApoB, and activity levels matter far more.

Main Topics: Why the episode is structured as a 'courtroom-style' evidence review (Priority: 5/5): Attia explains his desire for a debate format with pre-submitted evidence, discovery-like transparency, and fact-checking to reduce the usual podcast-debate noise and improve rigor. Historical RCTs on saturated fat vs polyunsaturated fats (Priority: 5/5): The Minnesota Coronary Experiment, Sydney Heart Study, Rose Corn Oil trial, VA/Finnish studies, and related meta-analyses are used to assess whether replacing saturated fat with PUFA changes mortality or cardiovascular outcomes. Trans fats as a major confounder (Priority: 5/5): A central argument is that several negative PUFA trials were contaminated by margarines containing high levels of trans fats, making it difficult to attribute harm to seed oils themselves. LDL/ApoB, oxidation, and atherosclerosis biology (Priority: 5/5): Norton argues the strongest causal evidence supports ApoB-containing lipoproteins as atherogenic, and explains why PUFA-enriched particles may oxidize more per particle but still reduce overall risk by lowering LDL burden and plaque-retention dynamics. Industrial processing and hexane concerns (Priority: 4/5): They examine whether extraction/refining chemicals and heat create harmful residues or oxidation products, concluding residue levels are tiny and generally implausible as a major chronic-health driver. Evolutionary/naturalness arguments and modern food patterns (Priority: 4/5): The conversation addresses claims that seed oils are unnatural and historically novel, arguing that 'natural' is not a reliable proxy for health and that modern disease patterns are driven more by excess calories, inactivity, and ultra-processed foods. Practical dietary takeaways for listeners (Priority: 4/5): Both speakers recommend focusing on larger levers—fiber, body weight, exercise, ApoB/LDL control, and food quality—rather than treating seed oils as a primary threat; if desired, substitute with olive oil/avocado oil, not more saturated fat.

Key Arguments: Seed oils are not shown to be uniquely harmful when compared isocalorically with other fats; the best controlled evidence overall is neutral to favorable for PUFA substitution. The most-cited negative RCTs are heavily confounded by trans fats, which were common in margarines used in those interventions. Longer and better-controlled trials without trans-fat confounding generally favor PUFA over saturated fat for cardiovascular outcomes. Mendelian randomization strongly supports a causal relationship between lifelong lower LDL/ApoB and lower cardiovascular risk, consistent across different genetic mechanisms. Oxidation matters, but most atherogenic oxidation occurs in the arterial intima, not the bloodstream; lowering the number of ApoB particles entering the vessel wall is more important than per-particle susceptibility. PUFA-enriched particles may be more oxidation-prone per particle, but they also lower LDL/ApoB, reduce entry into the intima, and are less aggregation-prone than saturated-fat-enriched particles. Hexane and other processing residues are present at extremely low levels in refined oils and are unlikely to be a major source of chronic harm. Evolutionary arguments are weak here because 'natural' does not equal healthy, and modern longevity/disease patterns are dominated by broader lifestyle and energy-balance issues. If someone wants to avoid seed oils, the meaningful goal is to replace them with better overall food choices and healthier fat sources—not to view saturated-fat-rich frying or ultra-processed 'seed-oil-free' foods as health foods. The biggest health levers remain caloric balance, physical activity, fiber intake, body composition, insulin sensitivity, blood pressure, and ApoB/LDL control.

Data Points: Minnesota Coronary Experiment duration: ~7 years (1966–1973) - Institutionalized-patient RCT replacing saturated fat with polyunsaturated fat Minnesota Coronary Experiment sample size: Nearly 9,000 subjects - Large controlled dietary trial cited in the seed oil debate Minnesota Coronary Experiment cholesterol effect: ~30 mg/dL decrease in total cholesterol - Observed in the low-saturated-fat/high-PUFA group Minnesota Coronary Experiment mortality effect: ~20%–22% increase in mortality - Associated with the cholesterol-lowering arm in reanalysis/discussion Margarine trans fat content: ~25%–40% trans fats - Common in the PUFA/margarine exposures that confounded early trials Sydney Heart Study mortality: 32% vs 20% mortality at 3 years - Higher mortality in the control group on saturated fat compared with PUFA arm as discussed Sydney Heart Study deaths: 37 treatment vs 28 control deaths - Total deaths were small, making estimates imprecise Rose Corn Oil trial sample: ~70 participants total - Very small trial comparing control, olive oil, and corn oil groups Rose Corn Oil trial cardiac deaths: 1 control, 3 olive oil, 6 corn oil - Used to illustrate how small samples produce unstable estimates Rose Corn Oil hazard ratio: 4.64 - Largest hazard ratio discussed; not statistically significant due to wide confidence intervals Rose Corn Oil confidence interval: 0.58 to 37.15 - Illustrates extreme imprecision in a tiny trial Meta-analysis effect without trans-fat confounding: ~20%–31% relative risk reduction - Referenced as the favorable summary when cleaner PUFA substitution trials are pooled Finnish hospital study duration: 6 years per diet, 12 years total - Crossover design in which participants served as their own controls Finnish hospital study effect: ~41% reduction in cardiovascular events/mortality risk - A key PUFA-favorable trial without trans-fat or omega-3 confounding VA study sample size: ~850 participants - Longer-duration trial in veterans' homes with controlled food intake VA study follow-up: Just under 9 years - Longer-term nutrition trial cited as higher quality VA study effect: ~18% risk reduction - Treatment arm had lower risk, though confidence intervals crossed unity LDL lowering in MR studies: ~50%–55% cardiovascular risk reduction per 1 mmol/L LDL drop - Genetic evidence for lifelong lower LDL exposure LDL lowering in statin trials: ~22% risk reduction per 1 mmol/L LDL drop - Used to explain different magnitude due to later-life treatment and cumulative exposure Average U.S. calorie intake: ~3,500 calories/day - Used to emphasize energy excess as a bigger public-health driver Average physical activity: <20 minutes/day - Used to underscore inactivity as a major factor in chronic disease Hexane residue in oils: ~0.05 to 0.5 parts per million - Estimated residual solvent levels in refined seed oils Hexane boiling point: 69°C - Used to explain removal during processing Potential oxidation threshold for oils: >200°C for hours - Discussed as far above typical extraction conditions Hadza LDL level: ~50 to 70 mg/dL average - Used as an evolutionary comparison for low ancestral LDL exposure PUFA substitution effect on LDL: ~15% reduction in LDL - Estimate for replacing saturated fat with PUFA Refining impact on oxidation markers: Peroxide values reduced ~5- to 10-fold - Processing was argued to reduce, not increase, certain oxidation measures

Pivotal Quotes: "The scientific method is perfect. It is a perfect method, but it is done by people who are not." — Lane Norton: On bias, interpretation, and why evidence must be weighed by totality rather than isolated studies "If you torture the data enough, it will confess what you want it to show." — Lane Norton: On overinterpreting small, messy trials and extracting misleading conclusions "We’re majoring in the minor and minoring in the major." — Peter Attia: Attia’s closing assessment that seed oils matter less than bigger drivers like calories, activity, and overall diet quality

Implications: For most listeners, seed oils are not the main health lever. Focus on calorie balance, fiber, exercise, and ApoB/LDL. Industry claims of 'seed-oil-free' health halo are overstated; better food quality matters more than swapping one cooking fat for another.

From the Transcript

Carb, animal-based, or carnivore. And if anybody has a bias towards high-quality animal protein, it's me. So I just want to start there and say that I think a lot of people, when the research conflicts with whatever their viewpoint is, they immediately jump to funding source or think that there's something nefarious going on. And what I will say is, the scientific method is perfect. It is a perfect method, but it is done by people who are not. And that is why it is so important to look at the Overall consensus of the evidence and looking at the different converging lines of evidence, which is something you'll probably hear me talk about a lot today, because I do think there's a lot of converging lines of evidence here. And that can give us a relatively strong or weak amount of confidence in how accurate something is or a statement is. And so I just want to put all that out there because when you're looking through scientific research or you're scrolling social media, if you have a bias towards something, you can always find a study.

Lane Norton · at 11:20

I mean, if we want to talk about a confidence interval being wide of 1.03 to 2.8 as being wide, the confidence interval in this, I believe, was like 0.6 to 37. I mean, so not statistically significant either. No, no, it was absolutely massive. But, and here's where my PhD advisor used to say: if you torture the data enough, it will confess what you want it to show. And so, if you just say, well, there was six times the number of deaths in the polyunsaturated group, you're technically correct. But you're leaving out a really big portion of the data. And again, when we plop all these studies into the meta-analysis, don't take out any confounding variables. What do we see? We see a null effect. Now, if we take out the trans fats, there was a meta-analysis, I think, in 2017, where they put together all the trials, there were human-randomized control trials looking at substitution of polyunsaturated fats for saturated fats not confounded by trans fat. This was a very clear benefit.

Lane Norton · at 38:50

Everything else being equal, having your LDL lower is better, all things being equal, to having it higher. All right. Well, Lane, I think that kind of brings this discussion to an end. I don't think this was necessarily as interesting as it would have been in its original format, where we could have done it as a genuine two-person point of view. I tend to agree with the point of view you've put forth. My own nomenclature on this is that we're majoring in the minor and minoring in the major. I just don't think this matters all that much, frankly. And my lack of enthusiasm around this topic is probably palpable. I also think I'd make one final point to what you said, which is there is another confounder with seed oils, which is that they tend to show up in low-quality foods. And therefore, if you make the decision to restrict your seed oils, you are probably doing a net benefit to yourself because you are simply going to eat less Oreos, less potato chips, less junky salad dressings.

Peter Attia · at 2:03:20
🔓 Sign Up for Unlimited Episode Search

About Peter Attia Drive

Expert insight on health, performance, longevity, critical thinking, and pursuing excellence. Dr. Peter Attia (Stanford/Hopkins/NIH-trained MD) talks with leaders in their fields.

View all episodes from Peter Attia Drive